Kaohsiung, Taiwan

Shyh-Ming Kuo

This inventor holds 1 USPTO granted patent. Top assignee: I-Shou University. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shyh-Ming Kuo. Retrieved from https://idiyas.com/inventor/shyh-ming-kuo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Shyh-Ming Kuo in Antibody Production

Introduction

Shyh-Ming Kuo is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of hybridoma cell lines for antibody production. His work is essential for advancing medical diagnostics and treatment options.

Latest Patents

One of Shyh-Ming Kuo's key patents is titled "Hybridoma cell line for producing antibody for type II collagen." This invention provides a hybridoma cell line (DSM ACC3145) that produces an antibody specifically binding to an amino acid sequence of type II collagen. The sequence comprises K-G-E-P-G-D-D-G-P-S-C, as set forth in SEQ ID NO. 1. This patent also outlines a method for detecting osteoarthritis by identifying the presence of type II collagen in a urine sample using the aforementioned antibody.

Career Highlights

Shyh-Ming Kuo is affiliated with I-Shou University, where he contributes to research and education in the field of biotechnology. His work has garnered attention for its potential applications in medical diagnostics, particularly in the detection of osteoarthritis.

Collaborations

Shyh-Ming Kuo has collaborated with notable colleagues, including Chih-Hsin Hung and I-Fen Chen. Their combined expertise enhances the research output and innovation in their respective fields.

Conclusion

Shyh-Ming Kuo's contributions to antibody production and medical diagnostics exemplify the impact of innovative research in biotechnology. His work continues to pave the way for advancements in healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…